Company Filing History:
Years Active: 2015
Title: Innovations of Hongcai Shang in Traditional Medicine
Introduction
Hongcai Shang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of traditional medicine, particularly in the development of medicaments for the treatment of myocardial infarction. His innovative approach combines ancient Chinese medicinal practices with modern medical applications.
Latest Patents
Hongcai Shang holds a patent for the use of a Chinese medicine composition in preparing medicaments for the secondary prevention of myocardial infarction. This patent, which is a testament to his expertise, involves a unique formula comprising various crude drugs. The composition includes Radix Astragali (22.2%–66.8%), Radix Salviae Miltiorrhizae (11.6%–33.4%), Radix Notoginseng (2.5%–13.5%), and Lignum Dalbergiae Odoriferae (14.5%–44.3%). This innovative formulation aims to enhance the efficacy of treatments for patients at risk of heart-related issues.
Career Highlights
Hongcai Shang is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry. His work at Tasly has allowed him to explore and develop traditional Chinese medicine further, bridging the gap between ancient practices and contemporary healthcare solutions. His dedication to research and innovation has positioned him as a key figure in the field.
Collaborations
Hongcai Shang has collaborated with notable colleagues, including Boli Zhang and Chen Yao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medicinal research.
Conclusion
Hongcai Shang's contributions to the field of traditional medicine exemplify the potential of integrating ancient practices with modern medical science. His innovative patent and work at Tasly Pharmaceutical Group Co., Ltd. highlight his commitment to improving healthcare outcomes through traditional Chinese medicine.